These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3838246)

  • 1. Neuropeptide Y-like immunoreactivity in neuritic plaques of Alzheimer's disease.
    Dawbarn D; Emson PC
    Biochem Biophys Res Commun; 1985 Jan; 126(1):289-94. PubMed ID: 3838246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical neurons immunoreactive with antisera against neuropeptide Y are altered in Alzheimer's-type dementia.
    Chan-Palay V; Lang W; Allen YS; Haesler U; Polak JM
    J Comp Neurol; 1985 Aug; 238(4):390-400. PubMed ID: 2413088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type.
    Dawbarn D; Rossor MN; Mountjoy CQ; Roth M; Emson PC
    Neurosci Lett; 1986 Sep; 70(1):154-9. PubMed ID: 2877420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin-like immunoreactivity within neuritic plaques.
    Armstrong DM; LeRoy S; Shields D; Terry RD
    Brain Res; 1985 Jul; 338(1):71-9. PubMed ID: 2862952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin immunoreactive neurons in the human hippocampus and cortex shown by immunogold/silver intensification on vibratome sections: coexistence with neuropeptide Y neurons, and effects in Alzheimer-type dementia.
    Chan-Palay V
    J Comp Neurol; 1987 Jun; 260(2):201-23. PubMed ID: 2886516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuritic pathology and dementia in Alzheimer's disease.
    McKee AC; Kosik KS; Kowall NW
    Ann Neurol; 1991 Aug; 30(2):156-65. PubMed ID: 1910274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: normal anatomy and alterations in Alzheimer's disease.
    Kowall NW; Beal MF
    Ann Neurol; 1988 Feb; 23(2):105-14. PubMed ID: 2897822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications.
    Papasozomenos SC
    Lab Invest; 1989 Jan; 60(1):123-37. PubMed ID: 2492060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein.
    Cras P; Kawai M; Lowery D; Gonzalez-DeWhitt P; Greenberg B; Perry G
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7552-6. PubMed ID: 1652752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of Alzheimer-related neuritic plaque pathology in the entorhinal region, perirhinal cortex and hippocampal formation.
    Yilmazer-Hanke DM; Hanke J
    Dement Geriatr Cogn Disord; 1999; 10(2):70-6. PubMed ID: 10026378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage-correlated distribution of type 1 and 2 dystrophic neurites in cortical and hippocampal plaques in Alzheimer's disease.
    Thal DR; Härtig W; Schober R
    J Hirnforsch; 1998; 39(2):175-81. PubMed ID: 10022341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunolocalization and redistribution of the FAC1 protein in Alzheimer's disease.
    Schoonover S; Davies P; Bowser R
    J Neuropathol Exp Neurol; 1996 Apr; 55(4):444-55. PubMed ID: 8786404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thy-1 in hippocampus: normal anatomy and neuritic growth in Alzheimer's disease.
    Leifer D; Kowall NW
    J Neuropathol Exp Neurol; 1992 Mar; 51(2):133-41. PubMed ID: 1347079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choline acetyltransferase immunoreactivity in neuritic plaques of Alzheimer brain.
    Armstrong DM; Bruce G; Hersh LB; Terry RD
    Neurosci Lett; 1986 Nov; 71(2):229-34. PubMed ID: 2431362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease. The density of amygdalar neuritic plaques is associated with the severity of neurofibrillary pathology and the degree of beta-amyloid protein deposition in the cerebral cortex.
    Yilmazer-Hanke DM
    Acta Anat (Basel); 1998; 162(1):46-55. PubMed ID: 9789108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plaque-associated neuronal proteins: a recurrent motif in neuritic amyloid deposits throughout diverse cortical areas of the Alzheimer's disease brain.
    Schmidt ML; DiDario AG; Otvos L; Hoshi N; Kant JA; Lee VM; Trojanowski JQ
    Exp Neurol; 1994 Dec; 130(2):311-22. PubMed ID: 7867760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of aluminium in neuritic plaque cores in Alzheimer's disease.
    Landsberg JP; McDonald B; Watt F
    Nature; 1992 Nov; 360(6399):65-8. PubMed ID: 1436075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease.
    Guo H; Albrecht S; Bourdeau M; Petzke T; Bergeron C; LeBlanc AC
    Am J Pathol; 2004 Aug; 165(2):523-31. PubMed ID: 15277226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau protein immunoreactivity in dementia of the Alzheimer type: II. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments.
    Papasozomenos SC
    Lab Invest; 1989 Mar; 60(3):375-89. PubMed ID: 2494388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease.
    Beal MF; Mazurek MF; Chattha GK; Svendsen CN; Bird ED; Martin JB
    Ann Neurol; 1986 Sep; 20(3):282-8. PubMed ID: 3767313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.